Millendo Therapeutics's activity chart (see below) currently has 14 price targets and 11 ratings on display.
Analysts' price targets on this stock were met 50% of the time, taking 122.78 days on average.
Most recent stock forecast was given by from LADENBURG on 06-Jan-2021. First documented stock forecast 12-Dec-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2020
$5
5 years 10 months 15 days ago
(06-Jan-2021)
2/2 (100%)
$-21.85 (-81.38%)
592
Buy Since 12-Dec-2018
$30
$360
5 years 10 months 15 days ago
(05-Jan-2021)
1/2 (50%)
$5.55 (22.70%)
20
Buy Since 11-Mar-2020
$25
6 years 7 months 15 days ago
(06-Apr-2020)
1/1 (100%)
$-73.7 (-74.67%)
26
Buy Since 07-Feb-2020
$20
$23
6 years 7 months 28 days ago
(24-Mar-2020)
2/2 (100%)
$-76.15 (-79.20%)
215
Buy Since 16-Jul-2019
$25
7 years 3 months 8 days ago
(13-Aug-2019)
2/2 (100%)
$-81.5 (-76.53%)
252
What is MLND (Millendo Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MLND (Millendo Therapeutics)?
Which analyst has the lowest performance score on MLND (Millendo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MLND (Millendo Therapeutics)?
Which analyst is the currently most bullish on MLND (Millendo Therapeutics)?
Which analyst is the currently most reserved on MLND (Millendo Therapeutics)?